Jannah Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.
USA

Abortion drug ruling: Supreme court retains access to mifepristone for now

Washington – Supreme Court Justice Samuel Alito on Friday suspended a lower court decision in a dispute over the Food and Drug Administration’s approval of the abortion drug mifepristone, preserving access to the drug for the time being.

Alito, which is processing a request for emergency relief from the U.S. Court of Appeals for the Fifth Circuit, has been granted a stay of control request from the Department of Justice as the court considers a request to intervene in a legal battle over mifepristone. I was. Restrictions on how late into pregnancy the drug can be taken, who can prescribe it and how it can be dispensed were set to go into effect at 1 a.m. Saturday.

Alito’s suspension was up until 11:59 p.m. Wednesday, when he instructed the Medical Association Against Abortion and doctors who challenged the FDA’s approval of the drug to respond by noon Tuesday.

Biden administration and drug maker Danko Laboratories officially asked the Supreme Court Intervene and block Friday Order April 7 The FDA’s approval of mifepristone in 2000 and subsequent actions to facilitate access to mifepristone by a federal district court judge.

Prior to reaching the Supreme Court, the Justice Department appealed the lower court’s decision to the Fifth Circuit Court of Appeals, requesting a stay of the decision of U.S. District Judge Matthew Kaksmalik.Late Wednesday, Court of Appeals pause Part of the decision to suspend FDA approval of mifepristone, but to tighten rules on the most common methods of early abortion, leaving the rest of the order to block changes made by the FDA from 2016. Did.

Changes made by the FDA to mifepristone include extending the drug’s use limit from 7 weeks to 10 weeks of pregnancy, reducing the number of in-person clinic visits required, and increasing the number of health care providers that allow the drug to be prescribed. included expanding the set of

The FDA also approved a generic version of mifepristone in 2019 and lifted the requirement to dispense tablets in person in 2021.

The Biden administration’s decision to seek emergency relief from the Supreme Court was not unexpected, and in its filings with the Fifth Circuit Court of Appeals, it said it would appeal to the Supreme Court if necessary, and has responded expeditiously to the decision. The latest move in legal action. From Kaksmalik. President Biden vowed to protect access to abortion, and White House Press Secretary Carine Jean-Pierre told reporters, “I believe the law is on our side, so the administration will win.” said.

“The Department of Justice strongly disagreed with the Fifth Circuit Court’s decision in Alliance for Hippocratic Medicine v. FDA and denied some of our requests for a stay pending appeal,” Judge Merrick Garland. said the chief. statement Thursday before the Department of Justice formally requested. “We plan to seek urgent relief from the Supreme Court to defend the FDA’s scientific judgment and protect Americans’ access to safe and effective reproductive medicine.”

The case is the most significant abortion rights-involving case to land in the Supreme Court since we ended the constitutional right to abortion. Overturn the Roe v. Wade case last year. The decision paved the way for more than a dozen states to almost completely ban abortion surgery, and many more imposed new laws limiting their ability to obtain abortion care.

However, the district court’s order and subsequent Fifth Circuit Court of Appeals decision contradict another decision by a Washington federal judge. This decision mandated the FDA to maintain the status quo regarding the availability of mifepristone in 16 states and the District of Columbia. Those states and DC he sued the Biden administration in February to try to preserve access to the drug over a series of restrictions placed on the drug.

The competing orders will only add more confusion and confusion to the legal situation upended by the Supreme Court’s reversal of Roe.

Referring to the turmoil following the conflicting court orders regarding mifepristone, Danko said, “The results are untenable for Danko, the donors, the women, and the entire healthcare system trying to navigate these uncharted waters. It’s half-hearted, and all after plaintiffs have waited years and years to claim irreparable injuries and require an emergency injunction to annul the decades-long status quo. ”

The challenge to FDA approval of mifepristone is the latest effort by anti-abortion advocates to limit access to abortion. The lawsuit was filed by a conservative legal body on behalf of physicians and medical associations. Federal Court in Amarillo, Texasonly Kacsmaryk hears the case.

Attorneys for the challengers allege that the FDA made a mistake in determining the safety and efficacy of mifepristone, and that the FDA granted regulatory authority when approving the drug more than 20 years ago. claimed to have exceeded

However, the FDA stresses that serious adverse events are extremely rare when mifepristone is used as directed by the agency, and more than 5 million women have taken the drug since 2000. I noticed that The agency said it had “obvious other causes” unrelated to abortion drug use.

More than half of all abortions in the United States in 2020 were medical abortions, according to the Centers for Disease Control and Prevention. Mifepristone is taken with a second drug, misoprostol, to terminate a pregnancy up to 10 weeks’ gestation.

As access to mifepristone is at risk, Democratic-led states enhance their supplies drugs and misoprostol shoot on your own Abort an early pregnancy. However, misoprostol-only medical abortion is slightly less effective (80% to 99%) than his two-drug regimen of mifepristone and misoprostol, which is 95% to 99% effective.

California Governor Gavin Newsom announced On Monday, states secured an emergency stockpile of up to 2 million misoprostol tablets. Governor of Massachusetts Maura Healey instructed State health care providers can bank higher doses of mifepristone. The University of Massachusetts Amherst has purchased about 15,000 doses, enough for the state to last her for more than a year, and is expected to arrive this week. New York Governor Kathy Hochul said Tuesday that the state will stockpile 150,000 doses of misoprostol for him.

Summarize this content to 100 words

Washington – Supreme Court Justice Samuel Alito on Friday suspended a lower court decision in a dispute over the Food and Drug Administration’s approval of the abortion drug mifepristone, preserving access to the drug for the time being.Alito, which is processing a request for emergency relief from the U.S. Court of Appeals for the Fifth Circuit, has been granted a stay of control request from the Department of Justice as the court considers a request to intervene in a legal battle over mifepristone. I was. Restrictions on how late into pregnancy the drug can be taken, who can prescribe it and how it can be dispensed were set to go into effect at 1 a.m. Saturday.Alito’s suspension was up until 11:59 p.m. Wednesday, when he instructed the Medical Association Against Abortion and doctors who challenged the FDA’s approval of the drug to respond by noon Tuesday.

Biden administration and drug maker Danko Laboratories officially asked the Supreme Court Intervene and block Friday Order April 7 The FDA’s approval of mifepristone in 2000 and subsequent actions to facilitate access to mifepristone by a federal district court judge.Prior to reaching the Supreme Court, the Justice Department appealed the lower court’s decision to the Fifth Circuit Court of Appeals, requesting a stay of the decision of U.S. District Judge Matthew Kaksmalik.Late Wednesday, Court of Appeals pause Part of the decision to suspend FDA approval of mifepristone, but to tighten rules on the most common methods of early abortion, leaving the rest of the order to block changes made by the FDA from 2016. Did.

Changes made by the FDA to mifepristone include extending the drug’s use limit from 7 weeks to 10 weeks of pregnancy, reducing the number of in-person clinic visits required, and increasing the number of health care providers that allow the drug to be prescribed. included expanding the set ofThe FDA also approved a generic version of mifepristone in 2019 and lifted the requirement to dispense tablets in person in 2021.The Biden administration’s decision to seek emergency relief from the Supreme Court was not unexpected, and in its filings with the Fifth Circuit Court of Appeals, it said it would appeal to the Supreme Court if necessary, and has responded expeditiously to the decision. The latest move in legal action. From Kaksmalik. President Biden vowed to protect access to abortion, and White House Press Secretary Carine Jean-Pierre told reporters, “I believe the law is on our side, so the administration will win.” said.”The Department of Justice strongly disagreed with the Fifth Circuit Court’s decision in Alliance for Hippocratic Medicine v. FDA and denied some of our requests for a stay pending appeal,” Judge Merrick Garland. said the chief. statement Thursday before the Department of Justice formally requested. “We plan to seek urgent relief from the Supreme Court to defend the FDA’s scientific judgment and protect Americans’ access to safe and effective reproductive medicine.”

The case is the most significant abortion rights-involving case to land in the Supreme Court since we ended the constitutional right to abortion. Overturn the Roe v. Wade case last year. The decision paved the way for more than a dozen states to almost completely ban abortion surgery, and many more imposed new laws limiting their ability to obtain abortion care.However, the district court’s order and subsequent Fifth Circuit Court of Appeals decision contradict another decision by a Washington federal judge. This decision mandated the FDA to maintain the status quo regarding the availability of mifepristone in 16 states and the District of Columbia. Those states and DC he sued the Biden administration in February to try to preserve access to the drug over a series of restrictions placed on the drug.The competing orders will only add more confusion and confusion to the legal situation upended by the Supreme Court’s reversal of Roe.Referring to the turmoil following the conflicting court orders regarding mifepristone, Danko said, “The results are untenable for Danko, the donors, the women, and the entire healthcare system trying to navigate these uncharted waters. It’s half-hearted, and all after plaintiffs have waited years and years to claim irreparable injuries and require an emergency injunction to annul the decades-long status quo. ”The challenge to FDA approval of mifepristone is the latest effort by anti-abortion advocates to limit access to abortion. The lawsuit was filed by a conservative legal body on behalf of physicians and medical associations. Federal Court in Amarillo, Texasonly Kacsmaryk hears the case.Attorneys for the challengers allege that the FDA made a mistake in determining the safety and efficacy of mifepristone, and that the FDA granted regulatory authority when approving the drug more than 20 years ago. claimed to have exceededHowever, the FDA stresses that serious adverse events are extremely rare when mifepristone is used as directed by the agency, and more than 5 million women have taken the drug since 2000. I noticed that The agency said it had “obvious other causes” unrelated to abortion drug use.

More than half of all abortions in the United States in 2020 were medical abortions, according to the Centers for Disease Control and Prevention. Mifepristone is taken with a second drug, misoprostol, to terminate a pregnancy up to 10 weeks’ gestation.As access to mifepristone is at risk, Democratic-led states enhance their supplies drugs and misoprostol shoot on your own Abort an early pregnancy. However, misoprostol-only medical abortion is slightly less effective (80% to 99%) than his two-drug regimen of mifepristone and misoprostol, which is 95% to 99% effective. California Governor Gavin Newsom announced On Monday, states secured an emergency stockpile of up to 2 million misoprostol tablets. Governor of Massachusetts Maura Healey instructed State health care providers can bank higher doses of mifepristone. The University of Massachusetts Amherst has purchased about 15,000 doses, enough for the state to last her for more than a year, and is expected to arrive this week. New York Governor Kathy Hochul said Tuesday that the state will stockpile 150,000 doses of misoprostol for him.

battle over abortion

more

more

https://www.cbsnews.com/news/abortion-pill-ruling-supreme-court-administrative-stay/ Abortion drug ruling: Supreme court retains access to mifepristone for now

Back to top button